In this episode, we explore the treatment algorithm for adult ADHD with Dr. Oscar Bukstein from Harvard Medical School. Should you start with stimulants or non-stimulants when substance use disorder complicates the picture? Discover how comorbidities like depression and anxiety reshape your medication selection strategy for optimal patient outcomes.

Faculty: Oscar G. Bukstein, M.D., M.P.H
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: Mastering Adult ADHD: A Comprehensive Clinical Guide
• Treatment Algorithm for Adult ADHD

In this episode, we explore pramipexole—a Parkinson's medication—as a promising add-on treatment for treatment-resistant bipolar depression. Could a dopamine agonist be the unexpected solution when standard mood stabilizers and antipsychotics fail? We examine the PAX-BD trial's findings, safety concerns, and practical clinical applications.

Faculty: Kristin Raj, M.D.
Host: Richard Seeber, M.D.

• Learn more about our membership here
• Earn 0.5 CME: Quick Take Vol. 78
• Treatment-Resistant Bipolar Depression: Is Adjunctive Pramipexole An Option?

In this episode, we explore the controversial role of SERT gene testing in predicting SSRI response with Dr. Chris Aiken. Can genetic testing really tell us which patients will respond to antidepressants, or are we putting too much faith in pharmacogenetic promises that lack solid evidence?

Faculty: Chris Aiken, M.D.
Host: Richard Seeber, M.D.

• Learn more about our memberships here
• Earn 0.75 CME: The Role of Genetic Testing in Psychiatry
• SERT Gene and SSRI Response: Is It Clinically Useful?